APA

Ohnuma H., Sato Y., Hayasaka N., Matsuno T., Fujita C., Sato M., Osuga T., Hirakawa M., Miyanishi K., Sagawa T., Fujikawa K., Ohi M., Okagawa Y., Tsuji Y., Hirayama M., Ito T., Nobuoka T., Takemasa I., Kobune M. & Kato J. (20181119). Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study. : Cancer science.

Chicago

Ohnuma Hiroyuki, Sato Yasushi, Hayasaka Naotaka, Matsuno Teppei, Fujita Chisa, Sato Masanori, Osuga Takahiro, Hirakawa Masahiro, Miyanishi Koji, Sagawa Tamotsu, Fujikawa Koshi, Ohi Motoh, Okagawa Yutaka, Tsuji Yasushi, Hirayama Michiaki, Ito Tatsuya, Nobuoka Takayuki, Takemasa Ichiro, Kobune Masayoshi and Kato Junji. 20181119. Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study. : Cancer science.

Harvard

Ohnuma H., Sato Y., Hayasaka N., Matsuno T., Fujita C., Sato M., Osuga T., Hirakawa M., Miyanishi K., Sagawa T., Fujikawa K., Ohi M., Okagawa Y., Tsuji Y., Hirayama M., Ito T., Nobuoka T., Takemasa I., Kobune M. and Kato J. (20181119). Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study. : Cancer science.

MLA

Ohnuma Hiroyuki, Sato Yasushi, Hayasaka Naotaka, Matsuno Teppei, Fujita Chisa, Sato Masanori, Osuga Takahiro, Hirakawa Masahiro, Miyanishi Koji, Sagawa Tamotsu, Fujikawa Koshi, Ohi Motoh, Okagawa Yutaka, Tsuji Yasushi, Hirayama Michiaki, Ito Tatsuya, Nobuoka Takayuki, Takemasa Ichiro, Kobune Masayoshi and Kato Junji. Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study. : Cancer science. 20181119.